| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 17 | 2024 | 98 | 5.040 |
Why?
|
| Transanal Endoscopic Surgery | 10 | 2024 | 23 | 3.910 |
Why?
|
| Digestive System Surgical Procedures | 14 | 2023 | 88 | 3.350 |
Why?
|
| Rectum | 14 | 2024 | 86 | 2.910 |
Why?
|
| Laparoscopy | 22 | 2023 | 426 | 2.720 |
Why?
|
| Colonoscopy | 9 | 2022 | 86 | 2.190 |
Why?
|
| Colectomy | 16 | 2019 | 104 | 1.950 |
Why?
|
| Anastomotic Leak | 5 | 2024 | 33 | 1.850 |
Why?
|
| Colonic Neoplasms | 10 | 2023 | 215 | 1.780 |
Why?
|
| Colon | 10 | 2024 | 136 | 1.660 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 263 | 1.580 |
Why?
|
| Postoperative Complications | 26 | 2024 | 1202 | 1.500 |
Why?
|
| Crohn Disease | 8 | 2021 | 105 | 1.440 |
Why?
|
| Anus Diseases | 3 | 2023 | 7 | 1.400 |
Why?
|
| Anastomosis, Surgical | 6 | 2024 | 107 | 1.350 |
Why?
|
| Colorectal Surgery | 7 | 2021 | 53 | 1.240 |
Why?
|
| Hemorrhoids | 2 | 2023 | 4 | 1.230 |
Why?
|
| Colonic Polyps | 2 | 2022 | 25 | 1.210 |
Why?
|
| Colostomy | 3 | 2022 | 23 | 1.200 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 323 | 1.150 |
Why?
|
| Treatment Outcome | 31 | 2024 | 5283 | 1.070 |
Why?
|
| Ileostomy | 3 | 2024 | 25 | 1.030 |
Why?
|
| Colitis, Ulcerative | 4 | 2020 | 71 | 1.020 |
Why?
|
| Perineum | 4 | 2021 | 19 | 1.020 |
Why?
|
| Hemorrhoidectomy | 2 | 2023 | 2 | 1.000 |
Why?
|
| Humans | 100 | 2024 | 59282 | 1.000 |
Why?
|
| Middle Aged | 55 | 2024 | 16310 | 1.000 |
Why?
|
| Rectal Diseases | 5 | 2020 | 28 | 0.950 |
Why?
|
| Diverticulitis | 3 | 2020 | 28 | 0.950 |
Why?
|
| Retrospective Studies | 40 | 2024 | 6071 | 0.900 |
Why?
|
| Surgeons | 3 | 2021 | 161 | 0.880 |
Why?
|
| Colonic Pouches | 2 | 2020 | 16 | 0.860 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2020 | 18 | 0.860 |
Why?
|
| Elective Surgical Procedures | 9 | 2021 | 112 | 0.830 |
Why?
|
| Colonic Diseases | 7 | 2020 | 34 | 0.810 |
Why?
|
| Pelvis | 2 | 2021 | 58 | 0.810 |
Why?
|
| Diverticulitis, Colonic | 5 | 2020 | 32 | 0.800 |
Why?
|
| Female | 65 | 2024 | 30695 | 0.790 |
Why?
|
| Male | 65 | 2024 | 27727 | 0.790 |
Why?
|
| Digestive System Fistula | 1 | 2021 | 3 | 0.760 |
Why?
|
| Reoperation | 3 | 2021 | 272 | 0.720 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2019 | 1525 | 0.690 |
Why?
|
| Clostridium Infections | 1 | 2020 | 45 | 0.660 |
Why?
|
| Academic Medical Centers | 3 | 2017 | 306 | 0.650 |
Why?
|
| Embolism, Air | 1 | 2018 | 8 | 0.630 |
Why?
|
| Delphi Technique | 1 | 2019 | 77 | 0.630 |
Why?
|
| Length of Stay | 11 | 2021 | 775 | 0.620 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 81 | 0.610 |
Why?
|
| Anal Canal | 4 | 2023 | 34 | 0.580 |
Why?
|
| Patient Readmission | 5 | 2020 | 420 | 0.560 |
Why?
|
| Aged | 38 | 2024 | 13412 | 0.560 |
Why?
|
| Telemedicine | 1 | 2022 | 307 | 0.560 |
Why?
|
| Rectal Fistula | 2 | 2015 | 20 | 0.550 |
Why?
|
| Adult | 37 | 2024 | 15663 | 0.530 |
Why?
|
| Abscess | 2 | 2015 | 76 | 0.530 |
Why?
|
| Total Quality Management | 1 | 2015 | 56 | 0.490 |
Why?
|
| Quality Improvement | 9 | 2019 | 416 | 0.490 |
Why?
|
| Neoplasm Staging | 8 | 2023 | 452 | 0.470 |
Why?
|
| Patient Safety | 1 | 2017 | 237 | 0.470 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 94 | 0.470 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2014 | 9 | 0.470 |
Why?
|
| Fecal Incontinence | 3 | 2024 | 28 | 0.460 |
Why?
|
| Pain, Postoperative | 4 | 2023 | 141 | 0.450 |
Why?
|
| Stromal Cells | 1 | 2014 | 65 | 0.440 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 78 | 0.440 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 326 | 0.440 |
Why?
|
| Anus Neoplasms | 3 | 2022 | 23 | 0.420 |
Why?
|
| Colon, Sigmoid | 2 | 2013 | 10 | 0.410 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 254 | 0.400 |
Why?
|
| Rectal Prolapse | 3 | 2019 | 11 | 0.400 |
Why?
|
| Morbidity | 6 | 2021 | 112 | 0.390 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 483 | 0.390 |
Why?
|
| Enteral Nutrition | 2 | 2002 | 54 | 0.380 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 112 | 0.380 |
Why?
|
| Risk Assessment | 7 | 2020 | 1920 | 0.370 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 69 | 0.370 |
Why?
|
| Health Status Disparities | 2 | 2013 | 137 | 0.360 |
Why?
|
| Internship and Residency | 6 | 2020 | 740 | 0.350 |
Why?
|
| General Surgery | 3 | 2020 | 191 | 0.340 |
Why?
|
| Cutaneous Fistula | 2 | 2015 | 7 | 0.330 |
Why?
|
| Risk Factors | 19 | 2020 | 4982 | 0.330 |
Why?
|
| Patient Discharge | 4 | 2021 | 489 | 0.310 |
Why?
|
| United States | 18 | 2024 | 7385 | 0.310 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2014 | 20 | 0.310 |
Why?
|
| Surgical Procedures, Operative | 3 | 2015 | 137 | 0.300 |
Why?
|
| Operative Time | 2 | 2021 | 76 | 0.300 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 2337 | 0.300 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2016 | 98 | 0.300 |
Why?
|
| Margins of Excision | 3 | 2024 | 24 | 0.290 |
Why?
|
| Surgical Wound Infection | 3 | 2014 | 110 | 0.290 |
Why?
|
| Surgical Flaps | 2 | 2023 | 110 | 0.290 |
Why?
|
| Recurrence | 3 | 2020 | 602 | 0.270 |
Why?
|
| Proctitis | 2 | 2020 | 6 | 0.270 |
Why?
|
| Prospective Studies | 6 | 2024 | 3065 | 0.270 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 5128 | 0.260 |
Why?
|
| Feasibility Studies | 2 | 2021 | 525 | 0.260 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 412 | 0.260 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2021 | 687 | 0.260 |
Why?
|
| Education, Medical, Graduate | 3 | 2020 | 315 | 0.250 |
Why?
|
| Colitis | 1 | 2006 | 75 | 0.240 |
Why?
|
| Intestinal Obstruction | 2 | 2018 | 49 | 0.240 |
Why?
|
| Adolescent | 10 | 2022 | 5822 | 0.240 |
Why?
|
| Quality of Life | 3 | 2024 | 1137 | 0.240 |
Why?
|
| Urinary Incontinence | 2 | 2015 | 40 | 0.230 |
Why?
|
| Cohort Studies | 5 | 2022 | 2372 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 299 | 0.220 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2014 | 33 | 0.220 |
Why?
|
| Preoperative Care | 3 | 2019 | 180 | 0.220 |
Why?
|
| Mesocolon | 1 | 2023 | 2 | 0.220 |
Why?
|
| Databases, Factual | 6 | 2016 | 813 | 0.220 |
Why?
|
| Perioperative Period | 2 | 2021 | 19 | 0.210 |
Why?
|
| Intestinal Fistula | 1 | 2003 | 10 | 0.210 |
Why?
|
| Consumer Health Information | 1 | 2022 | 36 | 0.200 |
Why?
|
| Home Care Services | 2 | 2020 | 97 | 0.200 |
Why?
|
| Critical Care | 3 | 2016 | 397 | 0.200 |
Why?
|
| Feces | 2 | 2020 | 97 | 0.200 |
Why?
|
| Gastric Emptying | 1 | 2002 | 6 | 0.200 |
Why?
|
| Propranolol | 1 | 2002 | 21 | 0.200 |
Why?
|
| Survival Rate | 5 | 2015 | 802 | 0.200 |
Why?
|
| Hospital Mortality | 3 | 2017 | 841 | 0.200 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 76 | 0.190 |
Why?
|
| Sarcopenia | 1 | 2022 | 18 | 0.190 |
Why?
|
| Burns | 1 | 2002 | 41 | 0.190 |
Why?
|
| Health Services Accessibility | 3 | 2015 | 521 | 0.190 |
Why?
|
| Medical Chaperones | 1 | 2021 | 3 | 0.190 |
Why?
|
| Abdominal Pain | 1 | 2022 | 94 | 0.190 |
Why?
|
| Oxycodone | 1 | 2021 | 30 | 0.190 |
Why?
|
| Military Personnel | 2 | 2013 | 97 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2014 | 236 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 69 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 147 | 0.180 |
Why?
|
| Energy Intake | 1 | 2002 | 167 | 0.180 |
Why?
|
| Drainage | 3 | 2013 | 148 | 0.180 |
Why?
|
| Abdomen | 3 | 2016 | 91 | 0.180 |
Why?
|
| Treatment Failure | 1 | 2021 | 185 | 0.180 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2020 | 17 | 0.170 |
Why?
|
| Safety | 1 | 2021 | 142 | 0.170 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2020 | 2 | 0.170 |
Why?
|
| Herpesvirus 2, Human | 1 | 2020 | 10 | 0.170 |
Why?
|
| Inappropriate Prescribing | 1 | 2021 | 64 | 0.170 |
Why?
|
| Prognosis | 5 | 2014 | 1599 | 0.170 |
Why?
|
| Online Systems | 1 | 2020 | 19 | 0.170 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 168 | 0.170 |
Why?
|
| Laparotomy | 2 | 2015 | 47 | 0.170 |
Why?
|
| Terminology as Topic | 1 | 2021 | 133 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 1561 | 0.170 |
Why?
|
| Precancerous Conditions | 2 | 2013 | 70 | 0.170 |
Why?
|
| Herpes Simplex | 1 | 2020 | 48 | 0.160 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 83 | 0.160 |
Why?
|
| Intestinal Diseases | 2 | 2014 | 34 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 2511 | 0.160 |
Why?
|
| Drug Utilization | 1 | 2021 | 208 | 0.160 |
Why?
|
| Herpesvirus 1, Human | 1 | 2020 | 78 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2002 | 359 | 0.160 |
Why?
|
| Insurance Coverage | 2 | 2016 | 94 | 0.160 |
Why?
|
| Time Factors | 7 | 2019 | 3614 | 0.160 |
Why?
|
| Unnecessary Procedures | 2 | 2016 | 43 | 0.160 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 169 | 0.160 |
Why?
|
| Young Adult | 10 | 2016 | 4266 | 0.150 |
Why?
|
| Social Media | 1 | 2020 | 117 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2018 | 76 | 0.150 |
Why?
|
| Pregnancy Complications | 2 | 2014 | 364 | 0.140 |
Why?
|
| Colon, Transverse | 1 | 2017 | 4 | 0.140 |
Why?
|
| Multivariate Analysis | 4 | 2021 | 902 | 0.140 |
Why?
|
| Hospital Costs | 2 | 2014 | 119 | 0.140 |
Why?
|
| Early Detection of Cancer | 3 | 2015 | 266 | 0.130 |
Why?
|
| Logistic Models | 5 | 2014 | 1232 | 0.130 |
Why?
|
| Adenoma | 2 | 2013 | 64 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 933 | 0.120 |
Why?
|
| Cholangiography | 1 | 2015 | 42 | 0.120 |
Why?
|
| Cholecystectomy | 1 | 2015 | 31 | 0.120 |
Why?
|
| Hernia | 1 | 2015 | 15 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2020 | 745 | 0.120 |
Why?
|
| Parenteral Nutrition | 2 | 2006 | 21 | 0.120 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 1479 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2020 | 95 | 0.120 |
Why?
|
| Bibliometrics | 1 | 2015 | 27 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 115 | 0.120 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2006 | 37 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2015 | 61 | 0.120 |
Why?
|
| Program Development | 1 | 2015 | 203 | 0.110 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 43 | 0.110 |
Why?
|
| Herniorrhaphy | 1 | 2015 | 69 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 110 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 72 | 0.110 |
Why?
|
| Recovery of Function | 2 | 2013 | 270 | 0.110 |
Why?
|
| Megacolon | 1 | 2014 | 1 | 0.110 |
Why?
|
| Incidence | 4 | 2014 | 1236 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2014 | 55 | 0.110 |
Why?
|
| Lacerations | 1 | 2014 | 16 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 39 | 0.110 |
Why?
|
| Pilonidal Sinus | 1 | 2013 | 2 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2013 | 4 | 0.110 |
Why?
|
| Tissue Adhesives | 1 | 2013 | 9 | 0.110 |
Why?
|
| Liver Failure | 1 | 2013 | 17 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2014 | 49 | 0.110 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 24 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 194 | 0.110 |
Why?
|
| Vancomycin | 1 | 2014 | 36 | 0.110 |
Why?
|
| Publishing | 1 | 2015 | 90 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 61 | 0.110 |
Why?
|
| Tertiary Healthcare | 1 | 2013 | 13 | 0.110 |
Why?
|
| Intensive Care Units | 4 | 2020 | 423 | 0.110 |
Why?
|
| Emergency Treatment | 1 | 2013 | 52 | 0.110 |
Why?
|
| Appendicitis | 1 | 2014 | 74 | 0.110 |
Why?
|
| HIV Infections | 1 | 2020 | 912 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2014 | 512 | 0.100 |
Why?
|
| Defecation | 1 | 2012 | 14 | 0.100 |
Why?
|
| Hospitals, Community | 1 | 2013 | 70 | 0.100 |
Why?
|
| Cesarean Section | 1 | 2014 | 95 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 34 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 516 | 0.100 |
Why?
|
| Reflex | 1 | 2012 | 27 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2012 | 38 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1025 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 166 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2014 | 377 | 0.100 |
Why?
|
| Mentors | 1 | 2013 | 115 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 249 | 0.100 |
Why?
|
| Minority Groups | 1 | 2013 | 135 | 0.100 |
Why?
|
| Observation | 1 | 2011 | 29 | 0.100 |
Why?
|
| Medical Records | 1 | 2012 | 133 | 0.100 |
Why?
|
| Sepsis | 1 | 2015 | 272 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 326 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 224 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 459 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 290 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 705 | 0.090 |
Why?
|
| Pregnancy | 3 | 2014 | 2202 | 0.080 |
Why?
|
| Ligation | 1 | 2010 | 33 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 132 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2006 | 674 | 0.080 |
Why?
|
| Acute Disease | 3 | 2016 | 659 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2013 | 127 | 0.080 |
Why?
|
| Insulin | 2 | 2002 | 674 | 0.080 |
Why?
|
| Animals | 5 | 2014 | 19601 | 0.080 |
Why?
|
| Data Accuracy | 2 | 2020 | 28 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 299 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 730 | 0.070 |
Why?
|
| Internet | 2 | 2022 | 449 | 0.070 |
Why?
|
| Comorbidity | 3 | 2017 | 1078 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2023 | 674 | 0.070 |
Why?
|
| Emergencies | 2 | 2010 | 111 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2046 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2373 | 0.060 |
Why?
|
| Inpatients | 2 | 2021 | 291 | 0.060 |
Why?
|
| Propensity Score | 2 | 2015 | 144 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 190 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 2059 | 0.060 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2024 | 21 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 862 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 203 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 56 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 1166 | 0.050 |
Why?
|
| Washington | 2 | 2013 | 23 | 0.050 |
Why?
|
| Search Engine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2002 | 461 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2002 | 7 | 0.050 |
Why?
|
| Intestines | 1 | 2004 | 158 | 0.050 |
Why?
|
| Workload | 2 | 2014 | 118 | 0.050 |
Why?
|
| Pylorus | 1 | 2002 | 10 | 0.050 |
Why?
|
| Syndrome | 1 | 2022 | 170 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2023 | 396 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2003 | 93 | 0.050 |
Why?
|
| Jejunum | 1 | 2002 | 14 | 0.050 |
Why?
|
| Glycogen | 1 | 2002 | 38 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2003 | 76 | 0.050 |
Why?
|
| Dietary Carbohydrates | 1 | 2002 | 58 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2002 | 114 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2021 | 47 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 131 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2014 | 470 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2003 | 189 | 0.050 |
Why?
|
| Liver | 1 | 2006 | 796 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2002 | 111 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 442 | 0.040 |
Why?
|
| Mice | 1 | 2014 | 10251 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 192 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 1252 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 136 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2020 | 13 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 73 | 0.040 |
Why?
|
| Age Factors | 2 | 2014 | 1504 | 0.040 |
Why?
|
| Computer Terminals | 1 | 1999 | 5 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 44 | 0.040 |
Why?
|
| Glucose | 1 | 2002 | 445 | 0.040 |
Why?
|
| Laparoscopes | 1 | 1999 | 24 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2020 | 176 | 0.040 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2018 | 1 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 214 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2018 | 19 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 55 | 0.040 |
Why?
|
| Universities | 1 | 2019 | 144 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2018 | 39 | 0.040 |
Why?
|
| Critical Illness | 1 | 2002 | 325 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 173 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 574 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4173 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 359 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2018 | 69 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 187 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 147 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2020 | 311 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 56 | 0.030 |
Why?
|
| Rats | 3 | 2006 | 1909 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1283 | 0.030 |
Why?
|
| Occult Blood | 1 | 2015 | 16 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2015 | 20 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 32 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 100 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2015 | 43 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1486 | 0.030 |
Why?
|
| Fissure in Ano | 1 | 2015 | 1 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 653 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2015 | 23 | 0.030 |
Why?
|
| Bile | 1 | 2015 | 19 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hawaii | 1 | 2015 | 22 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2015 | 36 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1782 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 2015 | 58 | 0.030 |
Why?
|
| Phospholipids | 2 | 2006 | 78 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 130 | 0.030 |
Why?
|
| Obstetrical Forceps | 1 | 2014 | 2 | 0.030 |
Why?
|
| Episiotomy | 1 | 2014 | 2 | 0.030 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2014 | 2 | 0.030 |
Why?
|
| Enema | 1 | 2014 | 12 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 355 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2014 | 47 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 97 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2014 | 156 | 0.030 |
Why?
|
| United States Department of Defense | 1 | 2013 | 1 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 6 | 0.030 |
Why?
|
| Wounds, Penetrating | 1 | 2013 | 23 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 332 | 0.030 |
Why?
|
| Ileum | 1 | 2013 | 19 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 101 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 266 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 297 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 228 | 0.030 |
Why?
|
| Gastroenterology | 1 | 2013 | 35 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 464 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 103 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2013 | 138 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 935 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2012 | 58 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2012 | 682 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2012 | 75 | 0.020 |
Why?
|
| Teaching | 1 | 2013 | 152 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 441 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 555 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 741 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2013 | 335 | 0.020 |
Why?
|
| Massachusetts | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Registries | 1 | 2014 | 801 | 0.020 |
Why?
|
| Mass Screening | 1 | 2015 | 645 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 409 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 243 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1290 | 0.020 |
Why?
|
| Decision Making | 1 | 2012 | 394 | 0.020 |
Why?
|
| Weight Loss | 1 | 2010 | 263 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 831 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 976 | 0.020 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2006 | 6 | 0.020 |
Why?
|
| Short Bowel Syndrome | 1 | 2006 | 5 | 0.020 |
Why?
|
| Smoking | 1 | 2010 | 826 | 0.020 |
Why?
|
| Random Allocation | 1 | 2006 | 192 | 0.020 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2006 | 36 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2004 | 31 | 0.010 |
Why?
|
| Ghrelin | 1 | 2002 | 18 | 0.010 |
Why?
|
| Animal Feed | 1 | 2002 | 16 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 164 | 0.010 |
Why?
|
| Nutritional Support | 1 | 2002 | 12 | 0.010 |
Why?
|
| Models, Educational | 1 | 1999 | 66 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 122 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 249 | 0.010 |
Why?
|